Spyre Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Spyre Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2015 to Q3 2024.
  • Spyre Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $10K, a 11.1% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $10K +$1K +11.1% Sep 30, 2024 10-Q/A 2024-11-18
Q2 2024 $10K $0 0% Jun 30, 2024 10-Q/A 2024-11-18
Q1 2024 $10K -$68K -87.2% Mar 31, 2024 10-Q/A 2024-11-18
Q4 2023 $9K -$674K -98.7% Dec 31, 2023 10-Q/A 2024-11-18
Q3 2023 $9K -$740K -98.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $10K -$742K -98.7% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $78K -$722K -90.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $683K -$159K -18.9% Dec 31, 2022 10-K/A 2024-11-18
Q3 2022 $749K -$148K -16.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $752K -$796K -51.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $800K +$84K +11.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $842K +$727K +632% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $897K +$775K +635% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $1.55M +$1.46M +1583% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $716K +$656K +1093% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $115K +$48K +71.6% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $122K +$8K +7.02% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $92K -$28K -23.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $60K -$689K -92% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $67K +$17K +34% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $114K +$65K +133% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $120K +$71K +145% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $749K +$616K +463% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $50K -$182K -78.4% Dec 31, 2018 10-K 2020-02-24
Q3 2018 $49K -$90K -64.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $49K -$90K -64.7% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $133K -$7K -5% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $232K +$192K +480% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $139K +$99K +248% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $139K +$121K +672% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $140K +$122K +678% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $40K +$20K +100% Dec 31, 2016 10-K 2018-03-13
Q3 2016 $40K Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $18K Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $18K Mar 31, 2016 10-Q 2016-05-19
Q4 2015 $20K Dec 31, 2015 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.